View AllPharmaBiotechMedical
14 August 2018
Concordia and the CMA – a drama in (at least) three parts

Last week, Concordia International released a management report in which it announced the names of six drugs...

14 August 2018
Different types of CAR-T

CAR-T cell therapy remains an exciting area in healthcare, and a potentially very lucrative one...

30 July 2018
The EMA’s clinical data publication policy: 1 year on

On 16 July 2018, the EMA published a report on the first year (Oct 2016...

4 July 2018
CJEU follows Advocate General’s Opinion to confirm the scope of the Specific Mechanism

On 21 June 2018 the CJEU gave its judgment in a preliminary reference from the...

3 July 2018
CAR-T keeps driving forward: a round-up of recent scientific and commercial developments

The pace of development in the CAR-T world, both scientific and commercial, is showing no...

20 June 2018
The CAT sets a clear framework for excessive and unfair prices in its Pfizer/Flynn judgment

The Competition Appeal Tribunal (CAT) recently gave its judgment in Pfizer and Flynn’s appeal of...

13 June 2018
Drafting leases for life sciences

Over the past decade, the UK life sciences sector has enjoyed rapid expansion, aided by...

8 June 2018
Driving immunotherapy forward: More than CAR-Ts

With two therapies already on the market and many more in the pipeline, CAR-T is...

14 May 2018
Depression Delayed: CMA’s paroxetine pay-for-delay case heads to Luxembourg

On 8 March 2018, the Competition Appeal Tribunal (CAT) gave an initial judgment in appeals brought by...

9 May 2018
The NHS gets on the bandwagon with CAR-T

Of interest to our UK readers will be the announcement by Simon Stevens, the chief...

9 May 2018
Can’t Stop the CAR-T

Despite it being only two months since our last review of the CAR-T world, the scientific and...

5 April 2018
We have our transition period for goods but what about the regulations? How the life sciences industry may be affected by Brexit

The European Commission published a Draft Withdrawal Agreement (the Agreement) on 19 March 2018. The Agreement...